Altimmune, Inc. Stock News

The market is searching for healthcare stocks that could be a major player in the Coronavirus Crisis. My speculative portfolio is loaded with some of these COVI

Bill Hearl is CEO and founder of Immunomic Therapeutics in Rockville.

Two coronavirus vaccine candidates are in the clinics and 42 more are in preclinical studies, according to updated data provided by the World Health Organization on March 20.Three biopharma companies

Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced that it is launching a collaboration with the University of Alabama at Birmingham (UAB) on the development of its sin

CORONAVIRUS could be the start of a new Cold War scenario, as the US and China continue to point the finger at each other, former Ministry of Defence Minister Tobias Ellwood has warned Express.co.uk.

Movers Indices • S&P 500 ETF (NYSE:SPY) decreased 2.46% to $254.50.• Nasdaq ETF (NASDAQ:QQQ) fell 2.65% to $186.81.• Dow Jones Industrial Average ETF (NYSE:DIA) decreased 3.05% to $217.97.• FT

Fly Intel: Pre-market Movers WW SCWX GME KBH ALT OCGN QFIN LULU TXMD HTZ GPS

Arlington Asset Investment (NYSE:AI) -21% after suspending Q1 dividend.BGC Partners (NASDAQ:BGCP) -20% on dividend cut.Altimmune (NASDAQ:ALT) -15% on FY earnings.Arbutus Biopharma (NASDAQ:ABUS)�

Here's a roundup of top developments in the biotech space over the last 24 hours.None of the NYSE- or Nasdaq-listed biotech stocks hit 52 week highs Thursday.Down In The Dumps (Biotech Stocks Hitting

GAITHERSBURG, Md., March 27, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the year ended December.

NEW YORK, NY / ACCESSWIRE / March 27, 2020 / Altimmune Inc (NASDAQ:ALT) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 27, 2020 at 8:30 AM Eas

Companies Reporting Before The Bell SecureWorks Corp. (NASDAQ: SCWX) is expected to report quarterly loss at $0.01 per share on revenue of $139.13 million. Sundial Growers Inc...

GAITHERSBURG, Md., March 25, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report financial results for the.

Largest borrow rate increases among liquid names WLL BLDP BHP TELL RRC ALT HEXO PLT LE INO

Tiziana Life Sciences PLC (NASDAQ:TLSA) +162% on potential coronavirus treatment.Phio Pharmaceuticals (NASDAQ:PHIO) +24% on Medigene deal.Inovio Pharmaceuticals (NASDAQ:INO) +21%.Altimmune (NASDAQ:A